fashion -WSS

fashion

author：comprehensive 2025-09-30 18:43:28 - browse：69

Illustration of a person walking across a tightrope, trying to balance. — Adobe

Hospitals are telling government officials it would be illegal to claw back $7.8 billion as part of a remedy that is making hospitals whole over underpaid drug discounts — and they may sue if that plan goes into effect.

The industry is walking a tightrope by trying to maximize the amount of money hospitals can keep. Lobbyists are praising federal officials for agreeing to dole out billions of dollars in future, lump-sum payments, but they are also pressuring Medicare not to offset a penny of those funds.

For several years during the Trump administration, Medicare cut payments for hospitals’ drugs under the federal 340B drug discount program, but the Supreme Court invalidated that policy in 2018. In July, Medicare proposed a solution: Hospitals would get $9 billion to cover what they are owed under the 340B program, but to offset those costs, the government would recoup $7.8 billion.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： The cancer drug shortage isn’t new — and neither are the solutions
Next article： The biotech scorecard for Q4: 16 stock

WSS

Nobel honors Karikó and Weissman's enduring partnership

Why getting cancer drugs just got harder for rural patients

FDA does about

International team creates first chimeric human

RaDonda Vaught to speak at CommonSpirit event on patient safety

European officials brace for rough respiratory virus season

knowledge

fashion

knowledge

Dobbs anniversary: the lost opportunity of abortion as health care

Readout Newsletter: Biotech news, Wall Street disappointment, Lilly's drug delays

New air purifier tech could be key to improving indoor air quality

Scientists unlock the key to scar

Apple is now the first public company to be valued at $3 trillion

What we owe ALS patients — and why one company fell short

Medical records are filled with copy

Kenai launches with $82 million for Parkinson’s stem cell therapy

Guidelines to prevent youth baseball injuries need more muscle

Kenai launches with $82 million for Parkinson’s stem cell therapy

hotspot

What will Novo Nordisk's VC do with its influx of cash?

Medicare innovation center doesn’t save money, experts say

Kristina Burow of ARCH Venture Partners shares her next big bets STAT

Congress extends some pandemic preparedness programs

FDA does about

Health insurers' Q3 question: how much care are people getting?

Wikipedia

entertainment

explore

hotspot